Julie Andersen
Julie Andersen
Unknown affiliation
Verified email at buckinstitute.org
Cited by
Cited by
Oxidative stress in neurodegeneration: cause or consequence?
JK Andersen
Nature medicine 10 (7), S18-S25, 2004
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease
D Kaur, F Yantiri, S Rajagopalan, J Kumar, JQ Mo, R Boonplueang, ...
Neuron 37 (6), 899-909, 2003
Glutathione, iron and Parkinson’s disease
S Bharath, M Hsu, D Kaur, S Rajagopalan, JK Andersen
Biochemical pharmacology 64 (5-6), 1037-1048, 2002
Cellular senescence: a link between cancer and age-related degenerative disease?
J Campisi, JK Andersen, P Kapahi, S Melov
Seminars in cancer biology 21 (6), 354-359, 2011
Dopaminergic neurons
SJ Chinta, JK Andersen
The international journal of biochemistry & cell biology 37 (5), 942-946, 2005
Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease
V Viswanath, Y Wu, R Boonplueang, S Chen, FF Stevenson, F Yantiri, ...
Journal of Neuroscience 21 (24), 9519-9528, 2001
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine
P Klivenyi, OA Andreassen, RJ Ferrante, A Dedeoglu, G Mueller, ...
Journal of Neuroscience 20 (1), 1-7, 2000
Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo
SJ Chinta, JK Mallajosyula, A Rane, JK Andersen
Neuroscience letters 486 (3), 235-239, 2010
Redox imbalance in Parkinson's disease
SJ Chinta, JK Andersen
Biochimica et Biophysica Acta (BBA)-General Subjects 1780 (11), 1362-1367, 2008
Cognitive efficiency on a match to sample task decreases at the onset of puberty in children
RF McGivern, J Andersen, D Byrd, KL Mutter, J Reilly
Brain and cognition 50 (1), 73-89, 2002
Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity: IMPLICATIONS FOR PARKINSON′ S DISEASE
N Jha, O Jurma, G Lalli, Y Liu, EH Pettus, JT Greenamyre, RM Liu, ...
Journal of Biological Chemistry 275 (34), 26096-26101, 2000
Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration
AL McCormack, JG Atienza, LC Johnston, JK Andersen, S Vu, ...
Journal of neurochemistry 93 (4), 1030-1037, 2005
The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway
J Peng, XO Mao, FF Stevenson, M Hsu, JK Andersen
Journal of Biological Chemistry 279 (31), 32626-32632, 2004
Time to talk SENS: critiquing the immutability of human aging
A Bartke, J Campisi, CB Heward, RJM Mccarter, G Stock
Ann. NY Acad. Sci 959, 452-462, 2002
MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology
JK Mallajosyula, D Kaur, SJ Chinta, S Rajagopalan, A Rane, DG Nicholls, ...
PloS one 3 (2), e1616, 2008
Oxidative and nitrative protein modifications in Parkinson's disease
SR Danielson, JK Andersen
Free Radical Biology and Medicine 44 (10), 1787-1794, 2008
Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson …
J Peng, FF Stevenson, SR Doctrow, JK Andersen
Journal of Biological Chemistry 280 (32), 29194-29198, 2005
Cellular senescence and the aging brain
SJ Chinta, G Woods, A Rane, M Demaria, J Campisi, JK Andersen
Experimental gerontology 68, 3-7, 2015
Does cellular iron dysregulation play a causative role in Parkinson’s disease?
D Kaur, J Andersen
Ageing research reviews 3 (3), 327-343, 2004
Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson’s disease
SJ Chinta, G Woods, M Demaria, A Rane, Y Zou, A McQuade, ...
Cell reports 22 (4), 930-940, 2018
The system can't perform the operation now. Try again later.
Articles 1–20